跳至主要内容
临床试验/CTRI/2022/11/047772
CTRI/2022/11/047772尚未招募3 期

A Single blind, Randomized, Parallel group study to compare efficacy and safety of Unani Medicine Kit formulationâ?? Cap Nazla with Tablet Levocetirizine in patients with Nazla Haar(Common cold/Allergic Rhinitis)

Central Council for Research in Unani Medicine (CCRUM), New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex in the age group of 18-65
  • 2. Patients of Nazla Haar presenting the following sign and symptoms:
  • Nasal irritation/ Nasal Itching
  • Redness of Face
  • Redness of Eyes
  • Discharge of yellowish secretion of thin
  • consistency

排除标准

  • 1. Known cases of Acute or Chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis.
  • 2. Fever > 100oF.
  • 3. Known cases of any other acute illness.
  • 4. Known cases of long standing chronic illnesses.
  • 5. Pregnant and lactating women.
  • 6. History of Addiction (smoking, alcohol)
  • 7. History of hepatic, renal disorders, Diabetes Mellitus, Hypertension, or any other ailment needing long term therapy

研究者

发起方
Central Council for Research in Unani Medicine (CCRUM), New Delhi

相似试验